Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.09
Percentage change -5.88	%

Held by: VTI IWM VXF VDC IWO SCHA VTWO IWC ITOT VTWG

Index	RUT	P/E	-	EPS (ttm)	-0.83	Insider Own	37.64%	Shs Outstand	122.90M	Perf Week	-4.00%
Market Cap	178.59M	Forward P/E	-	EPS next Y	-0.09	Insider Trans	0.09%	Shs Float	77.34M	Perf Month	-9.43%
Income	-83.69M	PEG	-	EPS next Q	-0.09	Inst Own	65.67%	Short Float	13.31%	Perf Quarter	-19.55%
Sales	366.21M	P/S	0.49	EPS this Y	70.47%	Inst Trans	-1.13%	Short Ratio	6.34	Perf Half Y	-67.64%
Book/sh	0.56	P/B	2.58	EPS next Y	38.97%	ROA	-9.74%	Short Interest	10.29M	Perf Year	-77.03%
Cash/sh	2.82	P/C	0.51	EPS next 5Y	-	ROE	-72.45%	52W Range	0.91 - 6.79	Perf YTD	-53.70%
Dividend Est.	-	P/FCF	141.74	EPS past 5Y	-96.50%	ROI	-13.23%	52W High	-78.79%	Beta	0.96
Dividend TTM	-	Quick Ratio	5.47	Sales past 5Y	34.83%	Gross Margin	33.44%	52W Low	58.24%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	6.49	EPS Y/Y TTM	-452.31%	Oper. Margin	-38.09%	RSI (14)	44.71	Volatility	8.41% 12.39%
Employees	881	Debt/Eq	8.20	Sales Y/Y TTM	-6.26%	Profit Margin	-22.85%	Recom	3.36	Target Price	1.74
Option/Short	Yes / Yes	LT Debt/Eq	8.14	EPS Q/Q	-500.79%	Payout	-	Rel Volume	0.74	Prev Close	1.53
Sales Surprise	-8.02%	EPS Surprise	-280.00%	Sales Q/Q	-22.88%	Earnings	Aug 08 AMC	Avg Volume	1.62M	Price	1.44
SMA20	-10.92%	SMA50	-11.94%	SMA200	-45.56%	Trades		Volume	1,204,070	Change	-5.88%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-23	Downgrade	Jefferies	Buy → Hold	$11 → $1.50
Nov-14-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-14-23	Downgrade	The Benchmark Company	Buy → Hold
Nov-14-23	Downgrade	TD Cowen	Outperform → Market Perform	$9 → $2.50
Nov-14-23	Downgrade	Raymond James	Mkt Perform → Underperform
Nov-14-23	Downgrade	Piper Sandler	Overweight → Underweight	$12 → $2
Nov-14-23	Downgrade	JP Morgan	Neutral → Underweight
Nov-14-23	Downgrade	Canaccord Genuity	Buy → Hold	$10 → $2.50
Aug-25-23	Resumed	Canaccord Genuity	Buy	$10
Jun-21-23	Downgrade	Stifel	Buy → Hold	$17 → $10
Mar-20-23	Upgrade	Exane BNP Paribas	Underperform → Neutral
Nov-09-22	Downgrade	JP Morgan	Overweight → Neutral	$22 → $11
Mar-11-22	Initiated	JP Morgan	Overweight	$24
Jan-07-22	Initiated	William Blair	Outperform
Dec-23-21	Initiated	Raymond James	Mkt Perform
Oct-08-21	Initiated	Stifel	Buy	$33
Oct-04-21	Initiated	Cowen	Outperform	$32
Jul-19-21	Initiated	Jefferies	Buy	$22
Jul-01-21	Initiated	Goldman	Buy	$31
Jun-28-21	Reiterated	The Benchmark Company	Buy	$16 → $22

Show Previous Ratings

Aug-08-24 04:35PM	BeautyHealth (NASDAQ:SKIN) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 22.5% (StockStory) -13.18%
04:05PM	BeautyHealth Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-30-24 08:00AM	BeautyHealth to Report Second Quarter 2024 Financial Results on August 8, 2024 (Business Wire)
May-10-24 12:45PM	The Beauty Health Company (NASDAQ:SKIN) Q1 2024 Earnings Call Transcript (Insider Monkey) -23.68%
May-09-24 06:30PM	Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q1 Earnings (Zacks)
06:10PM	Loading…
06:10PM	The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:40PM	BeautyHealth (NASDAQ:SKIN) Beats Q1 Sales Targets But Quarterly Guidance Underwhelms (StockStory)
04:05PM	BeautyHealth Reports First Quarter 2024 Financial Results (Business Wire)
Apr-26-24 08:00AM	BeautyHealth to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire) +5.88%
Apr-09-24 04:10PM	BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer (Business Wire)
Mar-28-24 01:38PM	15 Best Beauty Stocks To Invest In (Insider Monkey)
04:45AM	Should You Sell The Beauty Health Company (SKIN)? (Insider Monkey)
Mar-13-24 09:02AM	The Beauty Health Company (NASDAQ:SKIN) Q4 2023 Earnings Call Transcript (Insider Monkey) +18.38%
Mar-12-24 05:32PM	The Beauty Health Co Reports Mixed 2023 Financial Results Amidst Global Expansion (GuruFocus.com)
04:10PM	BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results (Business Wire)
04:05PM	Loading…
04:05PM	BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer (Business Wire)
Feb-29-24 04:06PM	BeautyHealth To Now Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 (Business Wire) +12.01%
Feb-27-24 04:05PM	BeautyHealth to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (Business Wire) +9.00%
Jan-13-24 02:04PM	Analyst Sees Further Downside for The Beauty Health Co. (SKIN) Amid Investor Suit Arising from Syndeo Mistakes Hagens Berman (GlobeNewswire)
Jan-10-24 11:30AM	BEAUTY HEALTH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-07-24 10:54AM	Beauty Health Company (SKIN) Faces Investor Lawsuit for Allegedly Concealing Syndeo's Frequent Treatment Interruptions Hagens Berman (GlobeNewswire)
Jan-01-24 09:38AM	Analyst Sees Further Downside For The Beauty Health Co. (SKIN) Amid Investor Suit Arising from Syndeo Mistakes Hagens Berman (GlobeNewswire)
Dec-29-23 01:53PM	Investors Allege Beauty Health Company (SKIN) Concealed Syndeo's Frequent Treatment Interruptions Hagens Berman (GlobeNewswire)
Dec-27-23 10:45AM	BEAUTY HEALTH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options (GlobeNewswire) -9.26%
Dec-25-23 11:06AM	Analyst Sees Further Downside For The Beauty Health Co. (SKIN) Amid Investor Suit Arising from Syndeo Mistakes Hagens Berman (GlobeNewswire)
Dec-22-23 02:15PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Beauty Health Company (SKIN) Investors Who Suffered Substantial Losses to Contact Firm, Securities Fraud Lawsuit Pending (GlobeNewswire)
Dec-19-23 12:41AM	Robbins LLP Reminds Investors of Lawsuit Against The Beauty Health Company and Approaching Lead Plaintiff Deadline (GlobeNewswire) +11.66%
Dec-18-23 04:03PM	Beauty Health Company (SKIN) Concealed Syndeo's Frequent Treatment Interruptions, Lawsuit Alleges Hagens Berman (GlobeNewswire)
Dec-12-23 08:00AM	BeautyHealth 2023 Skintuition Report: The Skin Health Trends and Data Shaping the Year (Business Wire)
Dec-11-23 12:14PM	Beauty Health Company (SKIN) Concealed Syndeo's Frequent Treatment Interruptions, Lawsuit Alleges Hagens Berman (GlobeNewswire)
01:24PM	Loading…
Dec-08-23 01:24PM	Investors Allege Beauty Health Company (SKIN) Concealed Syndeo's Frequent Treatment Interruptions Hagens Berman (GlobeNewswire)
Dec-05-23 05:35PM	SKIN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that The Beauty Health Company Investors with Substantial Losses Have Opportunity to Lead Case (Business Wire) -5.70% +5.69%
Dec-01-23 01:28PM	Investors Say the Beauty Health Company (SKIN) Concealed Issues with Syndeo Devices Hagens Berman (GlobeNewswire) +11.33%
Nov-27-23 09:10AM	Beauty Health Company (SKIN) Faces Lawsuit Over Allegedly Concealing Issues with Syndeo Devices Hagens Berman (GlobeNewswire)
Nov-21-23 04:15PM	Investors Say the Beauty Health Company (SKIN) Concealed Issues with Syndeo Devices Hagens Berman (GlobeNewswire)
Nov-20-23 04:28PM	The Beauty Health Company investors: Please contact the Portnoy Law Firm to recover your losses (GlobeNewswire)
Nov-17-23 08:35PM	Lost Money in The Beauty Health Company? Gibbs Law Group Investigates Potential Securities Law Violations (Business Wire) +26.97%
07:29PM	Investors Say the Beauty Health Company (SKIN) Concealed Issues with Syndeo Devices Hagens Berman (GlobeNewswire)
Nov-14-23 11:57AM	Why BeautyHealth (SKIN) Shares Are Sliding Today (StockStory) -64.36%
08:42AM	The Beauty Health Company (NASDAQ:SKIN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-13-23 04:43PM	The Beauty Health Co (SKIN) Faces Headwinds: Q3 Earnings Reveal Challenges and Revised Guidance (GuruFocus.com) +8.33%
04:10PM	BeautyHealth Reports Third Quarter 2023 Financial Results (Business Wire)
04:05PM	BeautyHealth Announces Leadership Transition (Business Wire)
Nov-07-23 06:12PM	BeautyHealth to Report Third Quarter 2023 Financial Results on November 13, 2023 (Business Wire) -5.61%
08:00AM	Hydrafacial and Dr. Dennis Gross Skincare Unveil Phyto-Retinol Booster for the Treatment Room (Business Wire)
Nov-01-23 08:00AM	Save and Glow: New MyBeautyHealth App Offers Consumer Loyalty Rewards on Every Hydrafacial Treatment (Business Wire)
Oct-30-23 08:00AM	BeautyHealth Launches Hydrafacial Tmall Store in China in First Direct to Consumer Commercial Play (Business Wire) -5.51%
Oct-10-23 08:00AM	BeautyHealth Supports Next Generation of Estheticians with Hydrafacial School Partner Program (Business Wire) +5.02%
Oct-02-23 08:00AM	BeautyHealth Brings Hydrafacial Syndeo to New Cowshed Spas at Soho House Location in the U.S. (Business Wire)
Sep-20-23 08:00AM	BeautyHealth to Initiate Stock Repurchase Program, Following Recent $100 Million Share Repurchase Authorization (Business Wire)
Sep-12-23 09:00AM	BeautyHealth Announces Business Transformation Program to Drive Profitability and Growth; Board of Directors Authorizes $100 Million Share Repurchase (Business Wire) +23.58%
Sep-07-23 08:32AM	BeautyHealth Opens Exclusive Hydrafacial Pop-Up Treatment Suites in Harrods (Business Wire)
Aug-25-23 09:42AM	Netflix upgraded, Olaplex downgraded: Wall Street's top analyst calls (The Fly)
Aug-24-23 08:00AM	BeautyHealth Expands In-Store Hydrafacial Treatments to Sephora Australia (Business Wire)
Aug-22-23 08:00AM	30,000 Hydrafacial Devices and Counting: BeautyHealths Flagship Brand Reaches New Milestone (Business Wire)
Aug-09-23 07:30AM	BeautyHealth Reports Second Quarter 2023 Financial Results (Business Wire) -5.44%
07:25AM	BeautyHealth Names Michael Monahan Chief Financial Officer (Business Wire)
Aug-04-23 08:00AM	BeautyHealth Partners with LaserAway® to Supply Hydrafacial Syndeo Devices to All U.S. Locations (Business Wire)
Aug-02-23 08:00AM	BeautyHealths SkinStylus Receives New FDA Clearance for Facial Acne Scarring (Business Wire)
Jul-26-23 08:00AM	BeautyHealth to Report Second Quarter 2023 Financial Results on August 9, 2023 (Business Wire)
Jul-17-23 08:00AM	Hydrafacial Debuts Custom Syndeo Device on Dior Spa Cruise 2023 (Business Wire)
May-23-23 08:00AM	BeautyHealth to Participate in TD Cowens 7th Annual Future of the Consumer Conference (Business Wire)
May-15-23 08:30AM	BeautyHealths Hydrafacial Announces Reimagined GLOWvolution Tour (Business Wire) +5.17%
May-10-23 07:30AM	BeautyHealth Reports First Quarter 2023 Financial Results (Business Wire) -6.73%
May-01-23 08:00AM	BeautyHealth Rings in Second Year as a Public Company with NASDAQ Opening Bell Ceremony (Business Wire)
Apr-26-23 08:00AM	BeautyHealth to Report First Quarter 2023 Financial Results on May 10, 2023 (Business Wire)
Apr-19-23 04:30PM	Maturing into a Multi-Brand Ecosystem, BeautyHealth Appoints Aesthetics Veteran Brad Hauser as Chief Operating Officer (Business Wire)
Apr-17-23 08:00PM	BeautyHealths Hydrafacial Opens New Beijing Experience Center, Signaling Continued Investment in High-Growth China Market (Business Wire)
Mar-30-23 04:00AM	Revolutionizing the Treatment Room: BeautyHealth Launches Connected Hydrafacial Syndeo Device in Europe and Asia (Business Wire)
Feb-28-23 07:30AM	BeautyHealth Reports Full Year and Fourth Quarter 2022 Financial Results (Business Wire) +11.40%
07:15AM	BeautyHealth to Acquire SkinStylus®, FDA-Cleared Microneedling Device (Business Wire)
Feb-27-23 08:00AM	Dior Powered by Hydrafacial (Business Wire)
Feb-21-23 12:01AM	BeautyHealths Hydrafacial and Prestige Skincare Brand Omorovicza Announce Global Launch of Advanced Skin Renewal Booster (Business Wire)
Feb-14-23 08:00AM	BeautyHealth to Report Fourth Quarter and Full-Year Fiscal 2022 Financial Results on February 28, 2023 (Business Wire)
Jan-12-23 09:00AM	New Clinical Study Finds Hydrafacial Clarifying Treatments Improve Acne Skin Concerns in 100 Percent of Participants (Business Wire)
Dec-07-22 08:00AM	BeautyHealths Hydrafacial Launches New Booster Developed with BABOR Laboratories in Germany (Business Wire)
Nov-11-22 08:00AM	BeautyHealth to Participate in Stifel 2022 Healthcare Conference (Business Wire)
Nov-10-22 08:00AM	BeautyHealth Enters Into $100 Million Accelerated Share Repurchase Agreement (Business Wire) +13.03%
Nov-08-22 07:30AM	BeautyHealth Reports Third Quarter 2022 Financial Results (Business Wire) -5.31%
Nov-07-22 08:30AM	BeautyHealths Hydrafacial Announces Co-Creation Partnership with Dr. Dennis Gross Skincare for Innovative New Booster (Business Wire)
Nov-04-22 08:00AM	BeautyHealths Hydrafacial Rolls Out New Triple AHA Exfoliating Booster with Professional Skincare Brand Glytone (Business Wire) +5.33%
Nov-02-22 08:00AM	BeautyHealth Appoints David Aquino as Executive Vice President Global Operations (Business Wire)
Oct-25-22 08:00AM	BeautyHealth to Report Third Quarter 2022 Financial Results on November 8, 2022 (Business Wire) +7.43%
Oct-05-22 08:30AM	Get ready to GLOW! Highly Anticipated Hydrafacial x JLo Beauty Booster Now Available in the U.S. (Business Wire)
Sep-27-22 08:00AM	BeautyHealth Announces $200 Million Share Repurchase Authorization (Business Wire) +11.35%
Sep-15-22 08:00AM	A Harbinger of Beauty Industry Resiliency, BeautyHealth Announces Three-Year Plan to Double Sales, At Least Triple Profit (Business Wire) +7.16%
Sep-14-22 12:50PM	BeautyHealths Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster (Business Wire)
Sep-13-22 08:00AM	BeautyHealths Hydrafacial Expands HFX Training Program to Paris and Singapore with Opening of Two New Experience Centers (Business Wire)
Sep-12-22 08:00AM	BeautyHealth Confirms Livestream for Investor Day on September 15, 2022 (Business Wire)
Aug-29-22 08:00AM	BeautyHealth Strengthens Commercial Leadership to Accelerate International Expansion, Naming Regional Presidents for EMEA, Southeast Asia (Business Wire)
Aug-12-22 06:09AM	The Beauty Health Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next (Simply Wall St.)
Aug-10-22 07:14AM	The Beauty Health Company (NASDAQ:SKIN) Is About To Turn The Corner (Simply Wall St.) +9.38%
Aug-09-22 10:00AM	Beauty Health Stock Jumps on Earnings. Its CEO Says Theres No Sign of a Slowdown. (Barrons.com) -16.18%
08:48AM	BeautyHealths Hydrafacial Joins New Wellness Floor at Galeries Lafayette Haussmann in Partnership with Exclusive Aesthetic Clinic Provider Innerskin (Business Wire)
07:30AM	BeautyHealth Reports Record Second Quarter 2022 Financial Results (Business Wire)
Aug-03-22 08:00AM	The Beauty Health Company to Host Investor Day on September 15, 2022 (Business Wire)
Jul-26-22 08:00AM	The Beauty Health Company to Report Second Quarter 2022 Financial Results on August 9, 2022 (Business Wire)
Jun-27-22 09:39AM	Loss-making Beauty Health (NASDAQ:SKIN) has seen earnings and shareholder returns follow the same downward trajectory over past -17% (Simply Wall St.)
Jun-15-22 08:00AM	BeautyHealths HydraFacial Introduces New Booster for Breakout-Prone Skin with Clinical Skincare Leader, Murad (Business Wire)
Jun-06-22 08:30AM	BeautyHealth Appoints Bluemercury Founder Marla Beck to Board of Directors (Business Wire)

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAUNDERS BRENT L	Chairman	Aug 12 '24	Buy	1.08	40,450	43,686	5,921,769	Aug 13 05:00 PM

Open in Screener

BLCO

Bausch + Lomb Corp

Sep 20 • 04:00PM ET

19.96

Dollar change -0.04
Percentage change -0.20	%

Healthcare • Medical Instruments & Supplies • Canada • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

BLCO Bausch + Lomb Corp daily Stock Chart

Held by: MGMT IPO DFAX DFIC DFSI QRFT

Index	-	P/E	-	EPS (ttm)	-1.30	Insider Own	88.98%	Shs Outstand	350.91M	Perf Week	28.36%
Market Cap	7.02B	Forward P/E	23.36	EPS next Y	0.85	Insider Trans	0.01%	Shs Float	38.79M	Perf Month	23.74%
Income	-456.00M	PEG	-	EPS next Q	0.16	Inst Own	11.54%	Short Float	5.69%	Perf Quarter	33.69%
Sales	4.50B	P/S	1.56	EPS this Y	-17.57%	Inst Trans	20.80%	Short Ratio	2.96	Perf Half Y	24.13%
Book/sh	18.49	P/B	1.08	EPS next Y	42.01%	ROA	-3.71%	Short Interest	2.21M	Perf Year	15.64%
Cash/sh	0.86	P/C	23.26	EPS next 5Y	18.00%	ROE	-6.77%	52W Range	13.16 - 21.00	Perf YTD	17.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-4.11%	52W High	-4.95%	Beta	0.46
Dividend TTM	-	Quick Ratio	1.01	Sales past 5Y	2.77%	Gross Margin	54.73%	52W Low	51.67%	ATR (14)	0.76
Dividend Ex-Date	-	Current Ratio	1.65	EPS Y/Y TTM	-222.37%	Oper. Margin	4.27%	RSI (14)	78.72	Volatility	5.44% 3.15%
Employees	13300	Debt/Eq	0.71	Sales Y/Y TTM	15.14%	Profit Margin	-10.14%	Recom	2.19	Target Price	19.42
Option/Short	Yes / Yes	LT Debt/Eq	0.71	EPS Q/Q	-370.10%	Payout	-	Rel Volume	0.83	Prev Close	20.00
Sales Surprise	3.86%	EPS Surprise	1.17%	Sales Q/Q	17.49%	Earnings	Jul 31 BMO	Avg Volume	746.38K	Price	19.96
SMA20	20.06%	SMA50	21.96%	SMA200	28.22%	Trades		Volume	616,622	Change	-0.20%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-24	Initiated	Raymond James	Outperform	$19
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$16 → $18
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$19 → $17
Dec-12-23	Initiated	Stifel	Hold	$16
Oct-03-23	Resumed	Evercore ISI	Outperform	$20
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$20
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight	$17
Sep-12-22	Initiated	H.C. Wainwright	Buy	$21
Jul-26-22	Initiated	RBC Capital Mkts	Outperform	$22
Jun-24-22	Initiated	Evercore ISI	Outperform	$21
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Wells Fargo	Overweight	$23
May-31-22	Initiated	Morgan Stanley	Equal-Weight	$22
May-31-22	Initiated	JP Morgan	Neutral	$20
May-31-22	Initiated	Jefferies	Buy	$25
May-31-22	Initiated	Guggenheim	Buy	$24
May-31-22	Initiated	Goldman	Neutral	$22
May-31-22	Initiated	Deutsche Bank	Hold	$19
May-11-22	Initiated	Cowen	Outperform	$35

Show Previous Ratings

Sep-18-24 11:01AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) +7.76%
Sep-16-24 06:35PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) +14.47%
12:26PM	Bausch + Lomb Stock Jumps Amid Reports Of A Sale (Investopedia)
09:52AM	Stocks to Watch Monday: DJT, Apple, Pfizer, Intel (The Wall Street Journal)
07:22AM	Bausch + Lomb explores sale amid parent company's debt woes - report (Investing.com)
11:37PM	Loading…
Aug-07-24 11:37PM	Insider Buying: CEO Brent Saunders Acquires Shares of Bausch & Lomb Corp (GuruFocus.com)
Aug-05-24 06:45PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -5.70%
Aug-01-24 10:41AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-31-24 03:55PM	Bausch + Lomb CEO Brent Saunders on growth opportunities (CNBC TV)
12:08PM	Bausch + Lomb CEO on strength in eye care, competitive positioning (CNBC TV)
07:00AM	Bausch + Lomb Announces Second-Quarter 2024 Results (Business Wire)
Jul-30-24 06:33PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-25-24 06:33PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-24-24 06:24PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -5.05%
Jul-17-24 06:53PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
12:05PM	Loading…
Jul-11-24 12:05PM	Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31 (Business Wire)
Jul-08-24 07:00AM	Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief (Business Wire)
Jun-17-24 07:00AM	Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress (Business Wire)
Jun-10-24 07:00AM	Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States (Business Wire)
Jun-03-24 07:00AM	Bausch + Lomb Launches Blink NutriTears Clinically Proven Nutritional Supplement for Dry Eyes in the United States (Business Wire)
May-29-24 04:30PM	Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results (Business Wire)
May-28-24 09:00AM	Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometrys Meeting (Business Wire)
06:59AM	Bausch + Lomb Receives Health Canada Approval for enVista Envy* Full Visual Range Intraocular Lens (Business Wire)
May-03-24 04:06PM	Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.18%
03:35PM	Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 03:03PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
May-01-24 11:54AM	BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace) -5.50%
08:33AM	Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening (GuruFocus.com)
06:58AM	Bausch + Lomb Announces First-Quarter 2024 Results (Business Wire)
Apr-29-24 07:00AM	Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting (Business Wire)
08:30AM	Loading…
Apr-25-24 08:30AM	Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes (Business Wire)
Apr-24-24 10:01AM	Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-18-24 07:00AM	Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs (Business Wire)
Apr-15-24 12:00PM	Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 (Business Wire)
Mar-27-24 07:00AM	Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting (Business Wire)
Mar-25-24 12:00PM	All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy (Zacks)
Mar-20-24 12:20PM	Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock (Zacks)
Mar-19-24 08:50AM	Eyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-08-24 10:10AM	Issuer Direct Corporation (AMEX:ISDR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 08:00AM	Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors (Business Wire)
Feb-23-24 03:05PM	Bausch + Lomb CEO Brent Saunders goes one-on-one with Jim Cramer (CNBC TV)
Feb-22-24 11:30AM	Bausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-21-24 10:35PM	Q4 2023 Bausch + Lomb Corp Earnings Call (Thomson Reuters StreetEvents) +13.78%
07:04PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
09:30AM	Compared to Estimates, Bausch + Lomb (BLCO) Q4 Earnings: A Look at Key Metrics (Zacks)
07:36AM	Bausch + Lomb Q4 Adj. Net Income Rises (RTT News)
07:31AM	Bausch & Lomb Corp (BLCO) Reports Robust Revenue Growth Amidst Net Loss in Q4 and Full-Year 2023 (GuruFocus.com)
07:00AM	Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO (GlobeNewswire)
06:58AM	Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance (Business Wire)
Feb-15-24 09:15AM	Seeking Clues to Bausch + Lomb (BLCO) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-14-24 12:10PM	Will Bausch + Lomb (BLCO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:00AM	Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-05-24 12:00PM	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21 (Business Wire)
Jan-17-24 06:54PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jan-09-24 12:41PM	Bausch + Lomb CEO: 2024 is the biggest year of new product launches the company has ever seen (CNBC TV)
Jan-08-24 06:59AM	Bausch + Lomb Receives FDA Approval for TENEO Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery (Business Wire)
Jan-03-24 09:00AM	Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-23 01:25PM	Bausch + Lomb CEO Brent Saunders Pays $35.35 Million for Chers Former Miami Beach Home (The Wall Street Journal)
Nov-15-23 06:59AM	Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs (Business Wire)
Nov-03-23 11:01AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Nov-01-23 03:19PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
09:21AM	Bausch & Lomb Corp (BLCO) Reports Q3 2023 Earnings and Raises Full-Year Guidance (GuruFocus.com)
06:58AM	Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance (Business Wire)
Oct-26-23 06:59AM	Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting (Business Wire)
Oct-16-23 12:00PM	Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1 (Business Wire)
Oct-04-23 06:59AM	Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting (Business Wire)
Sep-29-23 10:15AM	Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R) (ACCESSWIRE)
10:00AM	Bausch + Lomb Completes Acquisition of XIIDRA (Business Wire)
Sep-26-23 06:59AM	Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS in the United States (Business Wire)
Sep-20-23 06:59AM	Bausch + Lombs ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners (Business Wire)
Sep-19-23 08:32AM	Is the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock? (Zacks)
Sep-18-23 11:56AM	Novartis' (NVS) Shareholders Approve Sandoz Separation (Zacks)
Sep-14-23 05:25PM	Bausch + Lomb Announces Pricing of Senior Secured Notes Offering (Business Wire)
Sep-12-23 06:59AM	Bausch + Lomb Launches MIEBO (Perfluorohexyloctane Ophthalmic Solution) in the United States (Business Wire)
Sep-11-23 08:00AM	Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R) (ACCESSWIRE)
07:07AM	Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA® (Business Wire)
Sep-06-23 05:58PM	Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA® (Business Wire)
06:59AM	Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting (Business Wire)
Aug-29-23 07:00AM	Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference (Business Wire)
Aug-24-23 07:00AM	Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA® (Business Wire)
Aug-02-23 05:25PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
06:59AM	Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook (Business Wire)
Aug-01-23 08:00AM	Bausch + Lomb Solidifies Leadership Team (Business Wire)
Jul-11-23 07:00AM	Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2 (Business Wire)
Jul-06-23 07:00AM	Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops (Business Wire)
Jul-03-23 10:12AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jun-30-23 06:48PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
08:30AM	Bausch Healths Bausch + Lomb to Acquire Novartis XIIDRA(R) (ACCESSWIRE)
08:28AM	Bausch + Lombs CEO Inks First Big Deal Since Return (The Wall Street Journal)
08:00AM	Bausch + Lomb Will Acquire XIIDRA® (Business Wire)
Jun-14-23 09:43AM	A Look At The Intrinsic Value Of Bausch + Lomb Corporation (NYSE:BLCO) (Simply Wall St.)
Jun-12-23 07:00AM	Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States (Business Wire)
Jun-08-23 07:00AM	Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting (Business Wire)
Jun-06-23 07:00AM	Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States (Business Wire)
Jun-05-23 07:00AM	Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States (Business Wire)
Jun-01-23 07:00AM	Bausch + Lomb Announces Key Leadership Changes (Business Wire)
May-18-23 01:56PM	Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease (Business Wire)
08:50AM	The 6.3% return this week takes Bausch + Lomb's (NYSE:BLCO) shareholders one-year gains to 18% (Simply Wall St.)
May-08-23 06:53PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
May-03-23 06:59AM	Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance (Business Wire)

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAUNDERS BRENT L	CEO and Chairman of the Board	Aug 05 '24	Buy	15.66	32,250	505,067	595,169	Aug 07 05:29 PM

SKIN

Beauty Health Company

BLCO

Bausch + Lomb Corp

Upgrade your FINVIZ experience